Latest news
Novo Nordisk's Pill Launch Faces a Jury of Divided Analysts - AD HOC NEWSAD HOC NEWS · Mon, 10 Aug 2026 11:11:36 GMTNovo Nordisk's Oral Bet Faces Its First Real Test as Legal Clouds Lift - AD HOC NEWSAD HOC NEWS · Fri, 07 Aug 2026 20:21:37 GMTNovo CEO looks to speed up R&D as share drop shows gap with Lilly - ReutersReuters · Wed, 05 Aug 2026 15:33:40 GMTNovo CEO faces investor grilling after obesity drug disappointments - News24News24 · Wed, 05 Aug 2026 07:48:16 GMTNovo Nordisk Faces Its Most Consequential Week in Years as Legal Pressures and a Pill Rollout Collid - AD HOC NEWSAD HOC NEWS · Mon, 03 Aug 2026 16:13:07 GMTNovo Nordisk's Oral Weight-Loss Pill Faces Its Moment of Truth Amid Trial Setback and Lilly Legal Fi - AD HOC NEWSAD HOC NEWS · Mon, 03 Aug 2026 13:02:08 GMT